New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
07:15 EDTCGEN
theflyonthewall.com: Compugen discovers genetic biomarker for Predisposition to Type 2 diabetes
Compugen announced the discovery and experimental confirmation of a genetic biomarker, CGEN-40001 for predisposition to type 2 diabetes, the most common form of diabetes. This new biomarker was discovered using Compugen’s GeneVa® platform, which consists of an in silico database of approximately 350,000 predicted genetic variations in the human genome, with each predicted variation consisting of multiple consecutive nucleotides. :theflyonthewall.com



News For CGEN From The Last 14 Days
Check below for free stories on CGEN the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 2, 2010
07:10 EDTCGEN
theflyonthewall.com: Compugen discovers novel protein for treatment of autoimmune diseases
Compugen announced the discovery and experimental validation of CGEN-15001 for the treatment of autoimmune disorders. CGEN-15001 is the extracellular region of a previously unknown membrane protein in the B7/CD28 family. The existence and potential utility of the newly discovered parent protein from which CGEN-15001 is derived was predicted in silico utilizing Compugen’s LEADS Platform and other proprietary algorithms. :theflyonthewall.com